Samsara BioCapital, L.P. 13D and 13G filings for OnKure Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 5:28 pm Sale | 2025-06-30 | 13G | OnKure Therapeutics, Inc. OKUR | Samsara BioCapital, L.P. | 0 0.000% | -824,155 (Position Closed) | Filing |
| 2024-10-11 4:15 pm Purchase | 2024-10-04 | 13G | OnKure Therapeutics, Inc. OKUR | Samsara BioCapital, L.P. | 824,155 6.500% | 824,155 (New Position) | Filing |